cysteine has been researched along with naloxone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, J; Ryle, PR; Thomson, AD | 1 |
| Ishida, T; Kido, Y; Nagamatsu, K; Terao, T; Toki, S | 1 |
| Gioannini, TL; Hiller, JM; Onoprishvili, I; Simon, EJ | 1 |
| Blaschak, CJ; Johnson, PS; Montes, AE; Seidleck, BK; Surratt, CK; Wang, W; Wang, Z; Zhang, P; Zöllner, C | 1 |
| Deng, HB; Guang, W; Wang, JB | 1 |
| Chen, C; de Riel, JK; Huang, P; Javitch, JA; Li, J; Liu-Chen, LY; Xu, W | 1 |
| Chen, C; de Riel, JK; Huang, P; Javitch, JA; Li, J; Liu-Chen, LY; Shi, L; Weinstein, H; Xu, W | 1 |
| Barnes, TA; Calo, G; Carra, G; Guerrini, R; Kitayama, M; Lambert, DG; McDonald, J; Rowbotham, DJ; Smith, G | 1 |
| Frischknecht, R; Ott, D; Plückthun, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cysteine and naloxone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for cysteine and naloxone
| Article | Year |
|---|---|
The roles of the hepatocellular redox state and the hepatic acetaldehyde concentration in determining the ethanol elimination rate in fasted rats.
Topics: Acetaldehyde; Alcohol Dehydrogenase; Alcohol Oxidoreductases; Animals; Catechin; Cyanamide; Cysteine; Cytosol; Ethanol; Fasting; Kinetics; Liver; Male; Malonates; Mitochondria, Liver; NAD; Naloxone; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1985 |
Effect of morphinone on opiate receptor binding and morphine-elicited analgesia.
Topics: Analgesia; Animals; Cysteine; Dihydromorphine; Glutathione; Hydromorphone; Kinetics; Mice; Morphine; Naloxone; Receptors, Opioid | 1982 |
Inactivation of the purified bovine mu opioid receptor by sulfhydryl reagents.
Topics: Animals; Benzomorphans; Cattle; Cell Membrane; Corpus Striatum; Cysteine; Dithionitrobenzoic Acid; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Ethylmaleimide; Kinetics; Ligands; Naloxone; Radioligand Assay; Receptors, Opioid, mu; Sulfhydryl Reagents; Tritium | 1999 |
Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
Topics: Amino Acid Substitution; Animals; Chlorocebus aethiops; CHO Cells; COS Cells; Cricetinae; Cricetulus; Cysteine; Cystine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Humans; Ligands; Morphine; Mutagenesis, Site-Directed; Naloxone; Narcotic Antagonists; Nerve Tissue Proteins; Peptides; Point Mutation; Protein Binding; Protein Structure, Tertiary; Radioligand Assay; Receptors, Opioid, mu; Structure-Activity Relationship; Transfection | 1999 |
Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
Topics: Alanine; Amino Acid Sequence; Amino Acid Substitution; Animals; CHO Cells; COS Cells; Cricetinae; Cysteine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Ethyl Methanesulfonate; Humans; Ligands; Membranes; Mesylates; Molecular Sequence Data; Mutagenesis, Site-Directed; Naloxone; Narcotic Antagonists; Radioligand Assay; Receptors, Opioid, mu; Sulfhydryl Reagents | 2000 |
The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.
Topics: Amino Acid Sequence; Animals; Benzomorphans; Binding Sites; Cell Line; Conserved Sequence; Cysteine; Diprenorphine; Dose-Response Relationship, Drug; Ethyl Methanesulfonate; Glutamic Acid; Humans; Indicators and Reagents; Mesylates; Methionine; Molecular Sequence Data; Mutagenesis, Site-Directed; Naloxone; Narcotic Antagonists; Protein Structure, Secondary; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serine; Time Factors; Tritium | 2000 |
Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.
Topics: Amino Acid Substitution; Amino Acids; Animals; Binding, Competitive; Cysteine; Diprenorphine; Ethyl Methanesulfonate; Humans; Naloxone; Narcotic Antagonists; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2001 |
Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
Topics: Animals; Binding, Competitive; Cell Membrane; Cerebral Cortex; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Cysteine; Dose-Response Relationship, Drug; Electric Stimulation; Female; GTP-Binding Proteins; Male; Mice; Muscle Contraction; Naloxone; Narcotic Antagonists; Nociceptin; Opioid Peptides; Phenylalanine; Radioligand Assay; Rats; Rats, Wistar; Receptors, Opioid; Recombinant Proteins; Vas Deferens | 2003 |
Construction and characterization of a kappa opioid receptor devoid of all free cysteines.
Topics: Adenylyl Cyclases; Amino Acids; Animals; Blotting, Western; Cell Division; Cell Line; Cell Membrane; COS Cells; Cysteine; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Genetic Vectors; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Immunohistochemistry; Ligands; Microscopy, Confocal; Microscopy, Fluorescence; Models, Molecular; Mutation; Naloxone; Protein Binding; Protein Conformation; Protein Engineering; Protein Structure, Tertiary; Rats; Receptors, Opioid, kappa; Time Factors; Transfection | 2004 |